# Biomarker Monitoring in TP53 Mutation Carriers

> **NCT02289326** · — · COMPLETED · sponsor: **Scripps Health** · enrollment: 6 (actual)

## Conditions studied

- Li-Fraumeni Syndrome
- Hereditary Cancer Syndromes
- TP53 Gene Germline Mutation Carrier

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02289326
- **Lead sponsor:** Scripps Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02289326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02289326, "Biomarker Monitoring in TP53 Mutation Carriers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02289326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*